FDA
approval
· 2026-08-21
FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approves a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals Inc., indicating a label or indication update to the existing pr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMNESTEEM (ISOTRETINOIN)